2021
Comparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trial
Prado G, Abizaid A, Meireles G, Sarmento-Leite R, Prudente M, Cantarelli M, Dourado A, Mariani J, Perin M, Costantini C, Costa R, Costa J, Chamie D, Campos C, Ribeiro E, Lemos P. Comparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trial. Revista Portuguesa De Cardiologia 2021, 40: 71-76. DOI: 10.1016/j.repce.2020.05.024.Peer-Reviewed Original ResearchSirolimus-eluting stentsPrimary endpointClinical performanceDrug-eluting stentsFollow-upStent thrombosisDESTINY trialLong-term follow-upYears of follow-upAdverse cardiac eventsFive-year ratesOptical coherence tomographyTarget lesion revascularizationBiolimus-eluting stentFive-year resultsIntravascular ultrasound assessmentBiodegradable polymer drug-eluting stentsCardiac eventsRandomized studyUltrasound assessmentCardiac deathCoherence tomographyLesion revascularizationPolymer drug-eluting stentsRandomized trialsComparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trial
Prado G, Abizaid A, Meireles G, Sarmento-Leite R, Prudente M, Cantarelli M, Dourado A, Jr J, Perin M, Costantini C, Costa R, Costa J, Chamie D, Campos C, Ribeiro E, Lemos P. Comparative clinical performance of two types of drug-eluting stents with abluminal biodegradable polymer coating: Five-year results of the DESTINY randomized trial. Revista Portuguesa De Cardiologia 2021, 40: 71-76. PMID: 33402278, DOI: 10.1016/j.repc.2020.05.017.Peer-Reviewed Original ResearchConceptsSirolimus-eluting stentsPrimary endpointClinical performanceDrug-eluting stentsFollow-upStent thrombosisDESTINY trialLong-term follow-upYears of follow-upAdverse cardiac eventsFive-year ratesOptical coherence tomographyTarget lesion revascularizationBiolimus-eluting stentFive-year resultsIntravascular ultrasound assessmentBiodegradable polymer drug-eluting stentsCardiac eventsRandomized studyUltrasound assessmentCardiac deathCoherence tomographyLesion revascularizationPolymer drug-eluting stentsRandomized trials
2015
Metallic Limus‐Eluting Stents Abluminally Coated with Biodegradable Polymers: Angiographic and Clinical Comparison of a Novel Ultra‐Thin Sirolimus Stent Versus Biolimus Stent in the DESTINY Randomized Trial
Lemos P, Abizaid A, Meireles G, Sarmento-Leite R, Prudente M, Cantarelli M, Dourado A, Mariani J, Perin M, Costantini C, Costa R, Costa J, Chamie D, Campos C, Ribeiro E. Metallic Limus‐Eluting Stents Abluminally Coated with Biodegradable Polymers: Angiographic and Clinical Comparison of a Novel Ultra‐Thin Sirolimus Stent Versus Biolimus Stent in the DESTINY Randomized Trial. Cardiovascular Therapeutics 2015, 33: 367-371. PMID: 26352896, DOI: 10.1111/1755-5922.12159.Peer-Reviewed Original ResearchMeSH KeywordsAbsorbable ImplantsAgedBrazilCardiovascular AgentsCoated Materials, BiocompatibleCoronary AngiographyCoronary Artery DiseaseCoronary RestenosisCoronary ThrombosisCoronary VesselsDrug-Eluting StentsFemaleHumansMaleMiddle AgedMyocardial InfarctionPercutaneous Coronary InterventionPredictive Value of TestsProspective StudiesProsthesis DesignSirolimusTime FactorsTreatment OutcomeConceptsSirolimus-eluting stentsLate lumen lossRandomized trialsPrimary endpointLow dose of sirolimusLumen lossIn-stent late lumen lossBiolimus-eluting stentDose of sirolimusAngiographic in-stent late lumen lossOutcomes of patientsAdverse clinical eventsAngiographic late lumen lossDrug-eluting stent formulationsLimus-eluting stentsIncidence of deathClinical eventsClinical comparisonLow dosesStent thrombosisMyocardial infarctionStudy populationStentPatientsTrials
2013
Comparação da retração aguda do stent entre o suporte vascular bioabsorvível eluidor de everolimus e dois diferentes stents metálicos farmacológicos
Borghi T, Costa J, Abizaid A, Chamié D, Veloso e Silva M, Taiguara D, Costa R, Staico R, Feres F, Chaves Á, Siqueira D, Sousa A, Sousa J. Comparação da retração aguda do stent entre o suporte vascular bioabsorvível eluidor de everolimus e dois diferentes stents metálicos farmacológicos. Journal Of Transcatheter Interventions 2013, 21: 326-331. DOI: 10.1590/s2179-83972013000400005.Peer-Reviewed Original ResearchMetallic drug-eluting stentsPercutaneous coronary interventionDrug-eluting stentsBioresorbable vascular scaffoldAcute recoilSecond-generation metallic drug-eluting stentsAcute luminal gainNon-complex lesionsAngiographic characteristicsNo significant differenceEverolimus-eluting stentPolymeric materialsMaximum inflation pressureCoronary interventionBalloon deflationStentCobalt-chromium everolimus-eluting stentPatientsSignificant differenceVascular scaffoldsBiolimus-eluting stentInflation pressureLuminal gainHealing processBalloon
2011
Assessing the Temporal Course of Neointimal Hyperplasia Formation After Different Generations of Drug-Eluting Stents
Collet C, Costa J, Abizaid A, Chamié D, Staico R, Costa R, Siquera D, Obregon J, Feres F, Sousa A, Sousa J. Assessing the Temporal Course of Neointimal Hyperplasia Formation After Different Generations of Drug-Eluting Stents. JACC Cardiovascular Interventions 2011, 4: 1067-1074. PMID: 22017930, DOI: 10.1016/j.jcin.2011.07.010.Peer-Reviewed Original ResearchConceptsDrug-eluting stentsDiabetes mellitusSirolimus-eluting stentsNeointimal hyperplasiaFollow-upTreated with sirolimus-eluting stentsPresence of diabetes mellitusLong-term follow-upMonths to 5 yearsDrug-eluting stent implantationDe novo lesionsGenerations of drug-eluting stentsBiolimus-eluting stentIntravascular ultrasound evaluationNeointimal hyperplasia formationIntravascular ultrasound assessmentPrimary endpointNo significant differenceUltrasound assessmentUltrasound evaluationMean ageTemporal courseDiabetic patientsPatientsStent
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply